SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001104659-24-088446
Filing Date
2024-08-12
Accepted
2024-08-12 17:25:59
Documents
10
Effectiveness Date
2024-08-12

Document Format Files

Seq Description Document Type Size
1 S-3ASR tm2421205-1_s3asr.htm S-3ASR 481703
2 EXHIBIT 1.2 tm2421205d2_ex1-2.htm EX-1.2 226073
3 EXHIBIT 4.3 tm2421205d2_ex4-3.htm EX-4.3 332445
4 EXHIBIT 5.1 tm2421205d2_ex5-1.htm EX-5.1 33111
5 EXHIBIT 5.2 tm2421205d2_ex5-2.htm EX-5.2 6454
6 EXHIBIT 23.1 tm2421205d2_ex23-1.htm EX-23.1 2346
7 EX-FILING FEES tm2421205d2_ex-filingfees.htm EX-FILING FEES 37232
8 GRAPHIC lg_apogeetherapeutics-4c.jpg GRAPHIC 60707
9 GRAPHIC tm2421205d2_ex5-1img001.jpg GRAPHIC 3521
10 GRAPHIC tm2421205d2_ex5-2img001.jpg GRAPHIC 3521
  Complete submission text file 0001104659-24-088446.txt   1214340
Mailing Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453 650-394-5230
Apogee Therapeutics, Inc. (Filer) CIK: 0001974640 (see all company filings)

IRS No.: 934958665 | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-281503 | Film No.: 241198038
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)